Maxia Strategies specializes in creating efficient product development strategies and providing supporting regulatory services. Our primary focus is helping small to medium-sized enterprises maximize the value of their products throughout their development lifecycle.

Drug Development is Our Profession – Creating Value is Our Passion

R&D success continues to slide

18 February 2011

A BIO-sponsored study reports that despite continued growth in R&D spend, the chances of regulatory approvals has been falling in recent years, with success rates for drugs entering Phase 1 studies down to about 1 in 10.

For more information see:  Success rates for experimental drugs falls: study